In SURMOUNT-1, the most common adverse events at the 15 mg dose included nausea (31%), diarrhea (23%), constipation (11%), and vomiting (12%)
CNH BO
After washing in PBS, primary antibodies (IgM-PE BioLegend 406507, IgD-APC BioLegend 405713, MARCO Santa Cruz sc-65353/ anti-rat PE Abcam ab97058 and Siglec-1 Biolegend 142417) diluted in PBS 10% FCS were incubated overnight at 4 C
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Cagrilintide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
When to Choose BPC-157 BPC-157 is the better choice when your primary concern involves tissue damage or repair
Eur J Drug Metab Pharmacokinet 1991, 3648 Frolich J, Seccombe DW, Hahn P, et al